Reply: The spectrum of complement pathway activation is integral to the pathogenesis of severe COVID-19
Brain
.
2022 Nov 21;145(11):e118.
doi: 10.1093/brain/awac353.
Authors
Myoung-Hwa Lee
1
,
Daniel P Perl
2
,
Joseph Steiner
1
,
Nicholas Pasternack
1
,
Wenxue Li
1
,
Dragan Maric
1
,
Farinaz Safavi
1
,
Iren Horkayne-Szakaly
3
,
Robert Jones
3
,
Michelle N Stram
4
,
Joel T Moncur
3
,
Marco Hefti
5
,
Rebecca D Folkerth
4
,
Avindra Nath
1
Affiliations
1
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
2
Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
3
The Joint Pathology Center, Defense Health Agency, Silver Spring, MD 20910, USA.
4
Department of Forensic Medicine, New York University School of Medicine, New York, NY 10016, USA.
5
Department of Pathology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
PMID:
36327115
PMCID:
PMC10200281
DOI:
10.1093/brain/awac353
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
MeSH terms
COVID-19*
Complement Activation
Humans
SARS-CoV-2
Grants and funding
K23 NS109284/NS/NINDS NIH HHS/United States